Table 3.
Pattern of use | Reference | Adjusted OR (95% CI)* |
---|---|---|
Current user, 5 mg, for past 7 days | Non-user | 1.03 (1.02 to 1.11) |
Current user, 5 mg, for past 28 days | Non-user | 1.11 (1.08 to 1.26) |
Current user, 5 mg, for past 3 months | Non-user | 1.30 (1.21 to 1.45) |
Current user, 5 mg, for past 6 months | Non-user | 1.46 (1.31 to 1.65) |
Current user, 5 mg, for past 1 year | Non-user | 1.55 (1.41 to 1.88) |
Current user, 5 mg, for past 3 years | Non-user | 2.00 (1.69 to 2.26) |
Past user, 5 mg, for 6 months, stopped 6 months ago | Non-user | 1.06 (0.98 to 1.27) |
Current user, 5 mg, for past 6 months | Past user, 5 mg, for 6 months, stopped 6 months ago | 1.38 (1.07 to 1.61) |
Current user, 30 mg, for past 7 days | Non-user | 1.18 (1.13 to 1.86) |
Current user, 30 mg, for past 28 days | Non-user | 1.84 (1.58 to 4.00) |
Current user, 30 mg, for past 3 months | Non-user | 4.82 (3.12 to 9.29) |
Current user, 30 mg, for past 6 months | Non-user | 9.81 (5.13 to 19.92) |
Current user, 30 mg, for past 30 days | Past user, 30 mg, for 30 days, stopped 14 days ago | 1.07 (1.04 to 2.87) |
Current user, 30 mg, for past 30 days | Past user, 30 mg, for 30 days, stopped 28 days ago | 1.13 (1.07 to 4.30) |
Current user, 30 mg, for past 30 days | Past user, 30 mg, for 30 days, stopped 3 months ago | 1.40 (1.20 to 3.66) |
Current user, 30 mg, for past 14 days | Past user, 30 mg, for 14 days, stopped 28 days ago | 1.06 (1.03 to 2.79) |
Current user, 10 mg, for past 2 years | Past user, 10 mg, for 2 years, stopped 2 weeks ago | 1.10 (1.06 to 1.41) |
Current user, 10 mg, for past 2 years | Past user, 10 mg, for 2 years, stopped 1 month ago | 1.20 (1.12 to 1.61) |
Current user, 10 mg, for past 2 years | Past user, 10 mg, for 2 years, stopped 3 months ago | 1.55 (1.33 to 2.03) |
Current user, 10 mg, for past 2 years | Past user, 10 mg, for 2 years, stopped 6 months ago | 1.87 (1.32 to 2.63) |
Adjusted OR represents the relative risk of infection for the pattern of use in column one compared with the reference pattern of use in column two.